BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33964910)

  • 21. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
    Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships Between Forced Oscillatory Impedance and 6-minute Walk Distance After Pulmonary Rehabilitation in COPD.
    Zimmermann SC; Thamrin C; Chan AS; Bertolin A; Chapman DG; King GG
    Int J Chron Obstruct Pulmon Dis; 2020; 15():157-166. PubMed ID: 32021155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
    Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
    Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
    Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
    J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
    Kebriaei P; Hayes J; Daly A; Uberti J; Marks DI; Soiffer R; Waller EK; Burke E; Skerrett D; Shpall E; Martin PJ
    Biol Blood Marrow Transplant; 2020 May; 26(5):835-844. PubMed ID: 31505228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
    Moretti M; Fagnani S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteoglycan 4 is a diagnostic biomarker for COPD.
    Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation.
    Calverley PM; Page C; Dal Negro RW; Fontana G; Cazzola M; Cicero AF; Pozzi E; Wedzicha JA
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2733-2744. PubMed ID: 31819405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stromal cell therapy in COPD: from bench to bedside.
    Antunes MA; Lapa E Silva JR; Rocco PR
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3017-3027. PubMed ID: 29081655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients.
    Kruis AL; van Adrichem J; Erkelens MR; Scheepers H; In 't Veen H; Muris JW; Chavannes NH
    Int J Chron Obstruct Pulmon Dis; 2010 Nov; 5():407-13. PubMed ID: 21191435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
    Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
    Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
    Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
    Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study.
    Le Thi Bich P; Nguyen Thi H; Dang Ngo Chau H; Phan Van T; Do Q; Dong Khac H; Le Van D; Nguyen Huy L; Mai Cong K; Ta Ba T; Do Minh T; Vu Bich N; Truong Chau N; Van Pham P
    Stem Cell Res Ther; 2020 Feb; 11(1):60. PubMed ID: 32054512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease.
    Nickol AH; Frise MC; Cheng HY; McGahey A; McFadyen BM; Harris-Wright T; Bart NK; Curtis MK; Khandwala S; O'Neill DP; Pollard KA; Hardinge FM; Rahman NM; Armitage AE; Dorrington KL; Drakesmith H; Ratcliffe PJ; Robbins PA
    BMJ Open; 2015 Jul; 5(7):e007911. PubMed ID: 26150144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional profiling of circulating mononuclear cells from patients with chronic obstructive pulmonary disease receiving mesenchymal stromal cell infusions.
    Armitage JD; Tan DBA; Sturm M; Moodley YP
    Stem Cells Transl Med; 2021 Nov; 10(11):1470-1481. PubMed ID: 34405962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
    Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.